CymitQuimica logo

CAS 1714146-59-4

:

I-BRD9

Description:
I-BRD9, with the CAS number 1714146-59-4, is a selective inhibitor of the bromodomain and extraterminal (BET) family of proteins, particularly targeting BRD4. This compound is characterized by its ability to disrupt protein-protein interactions mediated by bromodomains, which play a crucial role in regulating gene expression and chromatin dynamics. I-BRD9 has been studied for its potential therapeutic applications in various cancers and inflammatory diseases, as it can modulate the transcriptional activity of oncogenes. The compound typically exhibits a moderate to high affinity for its target, and its efficacy is often evaluated in cellular and animal models. Additionally, I-BRD9's pharmacokinetic properties, such as solubility and bioavailability, are important for its development as a drug candidate. Overall, I-BRD9 represents a significant tool in epigenetic research and drug discovery, particularly in the context of diseases driven by aberrant gene expression.
Formula:C22H22F3N3O3S2
Synonyms:
  • CS-2328
  • 5-Ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]thieno[3,2-c]pyridine-2-carboximidamide
  • I-brd9 GSK602
  • Thieno[3,2-c]pyridine-2-carboximidamide, 5-ethyl-4,5-dihydro-4-oxo-N-(tetrahydro-1,1-dioxido-2H-thiopyran-4-yl)-7-[3-(trifluoromethyl)phenyl]-
  • I-BRD9;I-BRD-9
  • I-BRD9
  • N-(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)-5-ethyl-4-oxo-7-(3-(trifluoromethyl)phenyl)-4,5-di
  • GSK602
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.